PA
GSM icon

PharVision Advisers’s FerroAtlántica GSM Stock Holding History

PharVision Advisers’s Portfolio GSM Stock Details GSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-23,094
Closed -$95.1K – 88
2026
Q1 		$95.1K Sell
23,094
-32,298
-58% -$156K 0.97% 53
2025
Q4 		$257K Buy
+55,392
New +$256K 0.13% 375

Other funds holding GSM

CCPM
Cooper Creek Partners Management New York $4.21B AUM 44.81% 1-Year Est. Return
HP
Hosking Partners London, United Kingdom $3.01B AUM 83.99% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.65B AUM 47.79% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
OWIM
Old West Investment Management Los Angeles, California $944M AUM 90.26% 1-Year Est. Return
GC
Grizzlyrock Capital Chicago, Illinois $143M AUM 6.82% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CP
CenterBook Partners Greenwich, Connecticut $2.04B AUM 35.27% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

PharVision Advisers's GSM Position: Q2 2026 in Review

PharVision Advisers sold out of FerroAtlántica (GSM) in Q2 2026, closing a stake of 23,094 shares — an estimated $95.1K sold.

PharVision Advisers first reported a position in GSM in Q4 2025 and held it in 2 quarters. The position peaked at $257K in Q4 2025. 176 funds tracked by Wall St. Rank hold GSM as of Q2 2026.

  • PharVision Advisers reported no remaining FerroAtlántica position as of Q2 2026 after selling out during the quarter.
  • PharVision Advisers sold 23,094 FerroAtlántica shares in Q2 2026, an estimated $95.1K.
  • PharVision Advisers first reported a position in FerroAtlántica in Q4 2025 and held it in 2 quarters.
  • PharVision Advisers's FerroAtlántica position peaked at $257K in Q4 2025.
  • 176 funds tracked by Wall St. Rank held FerroAtlántica as of Q2 2026.

Based on PharVision Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.